Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of brenipatide in adults with diarrhea-predominant irritable bowel syndrome
CTR20261999Phase 2Active
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of brenipatide in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by Eli Lilly and Company. Started Jul 2026; status: active.
02
Drugs
brenipatide
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on CTR20261999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261999.